COM:ALEMBICPHARMACEUTICALS
Alembic Pharmaceuticals
- Stock
Last Close
1,037.85
22/11 06:40
Market Cap
196.41B
Beta: -
Volume Today
22.08K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 3.11B - | 3.59B 15.60% | 9.36B 160.56% | 5.25B 43.85% | 5.41B 3.03% | 7.49B 38.44% | 10.00B 33.43% | 13.68B 36.83% | 6.20B 54.67% | 3.55B 42.82% | 6.16B 73.67% | |
depreciation and amortization | 404.87M - | 444.13M 9.70% | 722.14M 62.60% | 829.70M 14.90% | 1.05B 27.11% | 1.15B 9.26% | 1.57B 36.53% | 1.83B 16.62% | 2.87B 56.31% | 2.75B 3.96% | 2.73B 1.00% | |
deferred income tax | ||||||||||||
stock based compensation | ||||||||||||
change in working capital | -720.72M - | -1.63B 125.47% | 1.35B 182.81% | -1.97B 246.05% | -1.81B 7.98% | 1.09B 160.01% | -5.93B 646.30% | 2.40B 140.41% | -3.67B 253.35% | -575.60M 84.33% | -956.50M 66.17% | |
accounts receivables | 361.90M - | -3.58B 1,089.94% | 5.11B 242.61% | -4.70B 191.91% | -2.23B 52.54% | 390.50M 117.52% | ||||||
inventory | -439.45M - | -719.92M 63.82% | -1.95B 170.60% | -629.60M 67.68% | -1.01B 60.71% | -2.33B 130.61% | -2.20B 5.60% | -2.99B 35.57% | -1.24B 58.63% | 1.34B 208.81% | -1.68B 225.17% | |
accounts payables | -527.70M - | -211.10M 60.00% | 452.70M 314.45% | 366.70M 19.00% | -281.70M 176.82% | 560.40M 298.94% | ||||||
other working capital | -281.27M - | -905.10M 221.79% | 3.29B 463.91% | -1.34B 140.55% | -796.70M 40.35% | 3.58B 549.89% | 68M 98.10% | -180.40M 365.29% | 1.89B 1,148.56% | 590.50M 68.78% | -224.60M 138.04% | |
other non cash items | -428.06M - | -692.22M 61.71% | -2.12B 206.24% | -1.23B 41.98% | -1.53B 24.76% | -1.61B 4.99% | -1.15B 28.51% | -3.28B 184.54% | 128M 103.91% | 1.51B 1,083.52% | 5.82B 283.85% | |
net cash provided by operating activities | 2.36B - | 1.72B 27.29% | 9.30B 441.68% | 2.89B 68.96% | 3.12B 8.18% | 8.12B 159.89% | 4.49B 44.69% | 14.63B 225.83% | 5.52B 62.26% | 7.24B 31.07% | 7.56B 4.40% | |
investments in property plant and equipment | -819.63M - | -2.24B 172.79% | -3.04B 35.80% | -4.70B 54.93% | -8.22B 74.70% | -7.64B 6.98% | -7.35B 3.86% | -6.60B 10.26% | -4.26B 35.46% | -4.43B 4.17% | -3.27B 26.15% | |
acquisitions net | -784.10M - | -143.60M 81.69% | 6M 104.18% | -4.60M 176.67% | 46.10M 1,102.17% | 18.70M 59.44% | 115.60M 518.18% | |||||
purchases of investments | -341.89M - | -81.27M 76.23% | -143.60M - | -15.20M 89.42% | -1.86B 12,143.42% | -1.39B 25.15% | -70M 94.97% | -83.20M 18.86% | ||||
sales maturities of investments | 36M - | 143.60M - | 9.20M 93.59% | 1.86B 20,128.26% | 1.87B 0.47% | -18.70M 101.00% | ||||||
other investing activites | 9.01M - | 21.59M 139.71% | 12.68M 41.29% | 206M 1,524.99% | 157.80M 23.40% | 231.30M 46.58% | 32.70M 85.86% | -1.79B 5,569.11% | 13.80M 100.77% | 28.20M 104.35% | 16.40M 41.84% | |
net cash used for investing activites | -810.62M - | -2.56B 215.33% | -3.10B 21.46% | -4.46B 43.71% | -8.84B 98.21% | -7.56B 14.56% | -7.32B 3.17% | -8.39B 14.65% | -3.72B 55.66% | -4.48B 20.33% | -3.23B 27.93% | |
debt repayment | -854.30M - | -371.99M 56.46% | -1.26B 239.83% | -381.20M 69.84% | -6.04B - | -2B 66.91% | -3.79B 89.63% | -3B 20.90% | -2B 33.33% | -2.05B 2.71% | ||
common stock issued | 7.34B - | |||||||||||
common stock repurchased | ||||||||||||
dividends paid | -545.78M - | -654.96M 20.01% | -652.70M 0.35% | -901M 38.04% | -907.60M 0.73% | -909.10M 0.17% | -3.26B 258.56% | -2.75B - | -1.97B 28.57% | -1.57B 20.00% | ||
other financing activites | -110.49M - | 1.89B 1,814.34% | -42.32M 102.23% | -6.50M 84.64% | 5.93B 91,390.77% | 7.54B 27.12% | 6.81B 9.75% | -9.52B 239.87% | 3.58B 137.58% | 1.35B 62.39% | -200K 100.01% | |
net cash used provided by financing activities | -1.51B - | 867.17M 157.41% | -1.96B 325.92% | -1.29B 34.22% | 5.03B 490.03% | 590.40M 88.25% | 1.55B 162.28% | -5.97B 485.81% | -2.17B 63.62% | -2.62B 20.52% | -3.88B 48.30% | |
effect of forex changes on cash | -1K - | 2K 300% | 100K - | -100K 200% | -700K 600% | 4.10M 685.71% | -9.30M 326.83% | -10K - | ||||
net change in cash | 41.02M - | 28.64M 30.18% | 4.24B 14,702.52% | -2.86B 167.51% | -693.40M 75.78% | 1.15B 266.33% | -1.27B 210.32% | 262.20M 120.61% | -369.70M 241.00% | 143.90M 138.92% | 443M 207.85% | |
cash at beginning of period | 161.06M - | 239.61M 48.77% | 268.26M 11.95% | 4.39B 1,537.69% | 1.53B 65.16% | 837.40M 45.30% | 1.99B 137.72% | 718.40M 63.91% | 980.60M 36.50% | 610.90M 37.70% | 822.70M 34.67% | |
cash at end of period | 202.08M - | 268.26M 32.75% | 4.51B 1,580.59% | 1.53B 66.04% | 837.40M 45.30% | 1.99B 137.72% | 718.40M 63.91% | 980.60M 36.50% | 610.90M 37.70% | 754.80M 23.56% | 1.27B 67.69% | |
operating cash flow | 2.36B - | 1.72B 27.29% | 9.30B 441.68% | 2.89B 68.96% | 3.12B 8.18% | 8.12B 159.89% | 4.49B 44.69% | 14.63B 225.83% | 5.52B 62.26% | 7.24B 31.07% | 7.56B 4.40% | |
capital expenditure | -819.63M - | -2.24B 172.79% | -3.04B 35.80% | -4.70B 54.93% | -8.22B 74.70% | -7.64B 6.98% | -7.35B 3.86% | -6.60B 10.26% | -4.26B 35.46% | -4.43B 4.17% | -3.27B 26.15% | |
free cash flow | 1.54B - | -518.23M 133.59% | 6.27B 1,309.46% | -1.82B 128.97% | -5.09B 180.50% | 475.90M 109.34% | -2.86B 700.48% | 8.04B 381.30% | 1.27B 84.24% | 2.81B 121.40% | 4.28B 52.68% |
All numbers in (except ratios and percentages)